论文部分内容阅读
Syntex 公司的缓释 Cardene 已获美国FDA 的批准。此品为尼卡地平口服缓释剂,每日2次,用于治疗高血压。1989年该公司已上市了1天3次的 Cardene,用于治疗心绞痛和高血压。缓释 Cardene 将于1992年7月进入市场。
Syndex’s sustained release Cardene has been approved by the U.S. FDA. This product is nicardipine oral sustained-release agent, 2 times daily for the treatment of hypertension. The company has marketed Cardene three times a day in 1989 for the treatment of angina and hypertension. The release of Cardene will enter the market in July 1992.